Development of ethosomal vesicular carrier for topical application of griseofulvin: effect of ethanol concentration

Chukwuemeka C. Mbah1, Philip F. Builders2, Chukwuma O. Agubata1, Anthony A. Attama3
1Department of Pharmaceutical Technology and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria
2Department of Pharmaceutical Technology and Raw Materials Development, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria
3Drug Delivery and Nanomedicines Research Group, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Agubata CO, Nzekwe IT, Attama AA, Müller-Goymann CC, Onunkwo GC (2015) Formulation, characterization and anti-malarial activity of homolipid-based artemether microparticles. Int J Pharm 478:202–222

Attama AA, Reichl S, Müller-Goymann CC (2008) Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 355:307–313

Attama AA, Reichl S, Müller-Goymann CC (2009) Sustained release and permeation of timolol from surface-modified solid-lipid nanoparticles through bioengineered human cornea. Curr Eye Res 34:698–705

Aulton ME (1999) Pharmaceutics: the science of dosage form design. Ist edn. Churchill Livingstone, Edinburgh

Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14(2):101–114

Bendas ER, Tadros MI (2007) Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS Pharm Sci Tech 8(4):E107

Brookfield Engineering Labs Inc (2014) More solutions to sticky problems: a guide to getting MORE from your Brookfield Viscometers 1–50. http://www.brookfieldengineering.com/education/viscosity_whymeasure.asp . Accessed 28 Feb 2014

Carter SJ (1987) Jellies formulation: sodium alginate. In: Cooper and gun’s dispensing for pharmaceutical students, 12th edn. Churchill Livingstone, Edinburgh, pp 214–218

Chernysheva YV, Babak VG, Kildeeva NR, Boury F, Benoit JP, Ubrich N, Maincent P (2003) Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsion-solvent evaporation. Mendeleev Commun 13:65–68

Chu KA, Yalkowsky SH (2009) An interesting relationship between drug absorption and melting point. Int J Pharm 373:24–40

Cilurzo F, Albert E, Minghetti P, Gennari CGM, Casiraghi A, Montanari L (2010) Effect of drug chirality on the skin permeability of ibuprofen. Int J Pharm 386:71–76

El Khyat A, Mavon A, Leduc M, Agache P, Humbert P (1996) Skin critical surface tension. Skin Res Technol 2(2):91–96

El Maghraby GM, Barry BW, Williams AC (2008) Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34:203–222

Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM (2007) Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1–16

Ghafourian T, Samaras EG, Brooks JD, Riviere JE (2010) Validated models for predicting skin penetration from different vehicles. Eur J Pharm Sci 41:612–616

Goodman M, Barry BW (1989) Action of penetration enhancers on human stratum corneum as assessed by differential scanning calorimetry. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption, 2nd edn. Marcel Dekker, New York, pp 567–595

GuhaSarkar S, Banerjee R (2010) Intravesical drug delivery: challenges, current status, opportunities and novel strategies. J Control Release 148:147–159

Jain S, Tiwary AK, Sapra B, Jain NK (2007) Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm Sci Tech 8(4):Article111. https://doi.org/10.1208/pt0804111

Karavelidis V, Giliopoulos D, Karavas E, Bikiaris DN (2010) Nanoencapsulation of a water soluble drug in biocompatible polyesters: effects of polyesters melting point and glass transition temperature on drug release behavior. Eur J Pharm Sci 41:636–643

Kulkarni PV, Roney CA, Antich PP, Bonte FJ, Raghu AV, Aminabhavi TM (2010) Quinoline-n-butylcyanoacrylatebased nanoparticles for brain targeting for the diagnosis of Alzheimer’s disease. WIREs Nanomed Nanobiotechnol 2:35–47

Kumar S, Malick AW, Meltzer NM, Mouskountankis JD, Behl CR (1992) Studies of in-vitro skin permeation and retention of a leucotriene antagonist from topical vehicles with a hairless guinea pig model. J Pharm Sci 81:631–634

Lee PJ, Langer R, Shastri VP (2005) Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci 94:912–917

Lipoid GmbH (2017) Phospholipids. www.lipoid.com/en/phospholipids . Accessed 3 Nov 2017

Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM (2005) Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1–12

Mandawgade SD, Patravale VB (2008) Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 363:132–138

Martin A, Swarbrick J, Cammarata A (1983) Physical pharmacy, 3rd edn. Lea and Febiger, Philadelphia, pp 445–468

Marto J, Vitor C, Guerreiro A, Severino C, Eleutério C, Ascenso A, Simões S (2016) Ethosomes for enhanced skin delivery of griseofulvin. Colloids Surf B 146:616–623

Mbah CC, Builders PF, Attama AA (2014a) Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Exp Opin Drug Deliv 11(1):45–59

Mbah C, Builders P, Nzekwe I, Kunle O, Adikwu M, Attama A (2014b) Formulation and in vitro evaluation of pH-responsive ethosomes for vaginal delivery of metronidazole. J Drug Deliv Sci Technol 24(6):565–571

Merck Index (1989) Stearic, oleic and linoleic acids, 11th edn. 1107, 1192, 1319. Merck & Co., Inc., New Jersey

Nguyen CA, Konan-Kouakou YN, Allemann E, Doelker E, Quintanar-Guerrero D, Fessi H, Gurny R (2006) Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating. AAPS Pharm Sci Tech 7(3):63. http://www.aapspharmscitech.org

Saito Y, Sato T, Anazawa I (1989) Correlation between distribution of oxyethylene chains of nonionic surfactants and stability of cyclohexane droplets. Colloid Surf 40:107–114

Schreier H, Bouwstra J (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 30:1–15

Semete-Makokotlela B, Kalombo L, Hayeshi R, Swai H (2011) Nanomedicine for improved efficacy of tuberculosis drugs. 4th ANDI Stakeholders Meeting 24–28 Oct., Addis Ababa

Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008) Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol 6:8. https://doi.org/10.1186/1477-3155-6-8

Shivanand P, Manish G, Viral D, Jarina F (2009) Transferosomes: a novel approach for transdermal drug delivery. Der Pharm Lett 1(2):143–150. http://scholarsresearchlibrary.com/archive.html

Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, Yamashita S (2006) Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a mini-scale dissolution test. Pharm Res 23:1144–1156

Touitou E (1996) Composition of applying active substances to or through the skin. US Patent, 5,716,638

Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–418

United States Pharmacopoeia (USP) 26 (2003) Asian ed., United States Pharmacopoeial Convention, Inc, Pharmacopoeia Rockville, p 875

Williams A (2003) Transdermal and topical drug delivery, 1st edn. Pharmaceutical Press, London

Xiong GL, Quan D, Maibach HI (1996) Effects of penetration enhacers on in vitro percutaneous absorption of low molecular weight heparin through human skin. J Control Release 42:289–296